CD27 and neoplasm: NKG2D CAR-T cells with the addition of CD27 as a co-stimulatory domain have anti-tumor activity against triple negative breast cancer in vitro and in vivo MDA-MB-231 fLuc xenograft NOD-SCIDIL2γc-/- (NSG) mouse model.